Skip to content
10-Q

Quarterly Report

Orion Biotech Opportunities Corp.

0001213900-22-047434

← back to feed
Filed
Aug 12, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$293.93K
Operating Cash Flow restated Q2 2022 · Jun 30, 2021 −$1.05M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $418.55K
Cash And Equivalents Q2 2022 · Dec 31, 2021 $712.47K
Stockholders Equity Q2 2022 · Jun 30, 2022 −$7.41M
Stockholders Equity Q2 2022 · Mar 31, 2022 −$9.14M
Stockholders Equity Q2 2022 · Dec 31, 2021 −$13.76M
Stockholders Equity restated Q2 2022 · Jun 30, 2021 −$15.12M
Stockholders Equity Q2 2022 · Mar 31, 2021 −$20.09K
Current Liabilities Q2 2022 · Jun 30, 2022 $40.29K
Current Liabilities Q2 2022 · Dec 31, 2021 $81.63K
Total Liabilities Q2 2022 · Jun 30, 2022 $8.33M
Total Liabilities Q2 2022 · Dec 31, 2021 $15.12M
Current Assets Q2 2022 · Jun 30, 2022 $821K
Current Assets Q2 2022 · Dec 31, 2021 $1.35M
Total Assets Q2 2022 · Jun 30, 2022 $201.12M
Total Assets Q2 2022 · Dec 31, 2021 $201.36M
Sga Expense Q2 2022 · Jun 30, 2022 $174.53K
Sga Expense Q2 2022 · Jun 30, 2022 $430.69K
Sga Expense Q2 2022 · Jun 30, 2021 $139.1K
Sga Expense Q2 2022 · Jun 30, 2021 $184.19K
Net Income Q2 2022 · Jun 30, 2022 $1.93M
Net Income Q2 2022 · Jun 30, 2022 $6.55M
Net Income Q2 2022 · Mar 31, 2022 $4.62M
Net Income Q2 2022 · Jun 30, 2021 −$2.05M
Net Income Q2 2022 · Jun 30, 2021 −$2.09M
Net Income Q2 2022 · Mar 31, 2021 −$45.09K
Operating Income Q2 2022 · Jun 30, 2022 −$204.53K
Operating Income Q2 2022 · Jun 30, 2022 −$490.69K
Operating Income Q2 2022 · Jun 30, 2021 −$153.62K
Operating Income Q2 2022 · Jun 30, 2021 −$198.71K